Categories: BodyMedTechOwnTechnology
RenBio believes medical benefits of antibody therapeutics should be available to everyone. With Make Your Own technology, antibody encoding “bioblueprints” are delivered by a modified intramuscular injection and then read by muscle cells to produce disease-fighting antibodies in the patient’s own body.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.05.2021 | Series A | $24M | - |
Mentions in press and media 2
| Date | Title | Description |
| 20.05.2021 | RenBio Receives $24M Series A Round |
NEW YORK, NY, RenBio today announced that it has completed a $24 million Series A financing.
>> Click here for more funding data on RenBio
>> To export RenBio funding data to PDF and Excel, click here
RenBio, a privately-... |
| 20.05.2021 | RenBio Raises $24M in Series A Funding | RenBio, a New York-based preclinical biotechnology company, raised $24m Series A funding.
The round was led by Taiwan-based Ruentex Group.
The company intends to use the funds to complete IND-enabling preclinical studies and initiate a Phas... |
Reviews 0
